In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $16.74 in the prior trading day, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $16.76, up 0.12%. In other words, the price has increased by $0.12 from its previous closing price. On the day, 0.63 million shares were traded. CGEM stock price reached its highest trading level at $16.79 during the session, while it also had its lowest trading level at $16.12.
Ratios:
Our goal is to gain a better understanding of CGEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’24 when Michaelson Jennifer sold 8,000 shares for $18.09 per share. The transaction valued at 144,720 led to the insider holds 115,942 shares of the business.
JENNIFER MICHAELSON & MARC D M bought 16,000 shares of CGEM for $298,880 on Sep 05 ’24. On Jul 05 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 8,000 shares for $16.33 each. As a result, the insider received 130,640 and left with 123,942 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 971687808 and an Enterprise Value of 311927488.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is -6.60%, while the 200-Day Moving Average is calculated to be -5.06%.
Shares Statistics:
The stock has traded on average 670.19K shares per day over the past 3-months and 878370 shares per day over the last 10 days, according to various share statistics. A total of 42.90M shares are outstanding, with a floating share count of 39.00M. Insiders hold about 32.74% of the company’s shares, while institutions hold 77.56% stake in the company. Shares short for CGEM as of 1726185600 were 8419812 with a Short Ratio of 12.56, compared to 1723680000 on 8155846. Therefore, it implies a Short% of Shares Outstanding of 8419812 and a Short% of Float of 16.85.
